APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digital Pathology

Digital Pathology, which also refers as virtual microscopy, incorporates capturing, sharing, managing, interpreting and analysing the digital information from a glass slide. Pathology is a study of disease whether caused by pathogens or non- infectious, physical disorder; it refers to the scientific study of disease processes; it occupies a vital role in all type of drug discoveries. Digital pathology technology is widely used in the scanners, software, communication systems and storage systems and helps in the improvement of operational efficiency, enhancing productivity, developments in treatment decisions and patient care. In the year 1990s principle of virtual microscopy is used in the life science areas, and in the year 2000 scientific community agreed the term digital pathology denote digitisation efforts in pathology and later digital pathology technology is used in the various kind of applications.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Digital Pathology, which also refers as virtual microscopy, incorporates capturing, sharing, managing, interpreting and analysing the digital information from a glass slide. Pathology is a study of disease whether caused by pathogens or non- infectious, physical disorder; it refers to the scientific study of disease processes; it occupies a vital role in all type of drug discoveries. Digital pathology technology is widely used in the scanners, software, communication systems and storage systems and helps in the improvement of operational efficiency, enhancing productivity, developments in treatment decisions and patient care. In the year 1990s principle of virtual microscopy is used in the life science areas, and in the year 2000 scientific community agreed the term digital pathology denote digitisation efforts in pathology and later digital pathology technology is used in the various kind of applications.

Selected research

Market Analysis & Forecast

Global Digital Pathology Market Analysis and Forecast 2026-2032

20 December 2025200 pages

Choose your research edition.

Industry ResearchDigital Pathology Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Pathology Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Digital Pathology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Pathology Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Pathology Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

Digital Pathology, which also refers as virtual microscopy, incorporates capturing, sharing, managing, interpreting and analysing the digital information from a glass slide. Pathology is a study of disease whether caused by pathogens or non- infectious, physical disorder; it refers to the scientific study of disease processes; it occupies a vital role in all type of drug discoveries. Digital pathology technology is widely used in the scanners, software, communication systems and storage systems and helps in the improvement of operational efficiency, enhancing productivity, developments in treatment decisions and patient care. In the year 1990s principle of virtual microscopy is used in the life science areas, and in the year 2000 scientific community agreed the term digital pathology denote digitisation efforts in pathology and later digital pathology technology is used in the various kind of applications.

Global Digital Pathology key players include Danaher, Hamamatsu Photonics, Roche, etc. Global top three manufacturers hold a share over 30%.

North America is the largest market, with a share over 40%, followed by Europe and China, both have a share over 35 percent.

Read the full market overview

In terms of product, Digital IVD Devices is the largest segment, with a share over 35%. And in terms of application, the largest application is Hospital & Diagnostic Centers, followed by Pharma & Biotech Companies.

Report Includes

This report presents an overview of global market for Digital Pathology, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Digital Pathology, also provides the revenue of main regions and countries. Of the upcoming market potential for Digital Pathology, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Digital Pathology revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Digital Pathology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Digital Pathology revenue, projected growth trends, production technology, application and end-user industry.

Digital Pathology Segment by Company

Danaher

Hamamatsu Photonics

Roche

Philips

Olympus

PerkinElmer

Sectra

Nikon

Definiens

3DHISTECH

Visiopharm

Apollo Enterprise Imaging

Glencoe Software

Indica Labs

OptraSCAN

Objective Pathology

Digipath

Pathcore

Digital Pathology Segment by Type

Whole Slide Imaging

Image Analysis-Informatics

Information Management System Storage & Communication

Digital IVD Devices

Others

Digital Pathology Segment by Application

Pharma & Biotech Companies

Hospital & Diagnostic Centers

Educational Institutes

Digital Pathology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Pathology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Pathology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Pathology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Digital Pathology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Digital Pathology company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital Pathology revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Digital Pathology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Whole Slide Imaging Major Player Table 3. Image Analysis-Informatics Major Player Table 4. Information Management System Storage & Communication Major Player Table 5. Digital IVD Devices Major Player Table 6. Others Major Player Table 7. Global Digital Pathology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Pharma & Biotech Companies Major Player Table 9. Hospital & Diagnostic Centers Major Player Table 10. Educational Institutes Major Player Table 11. Digital Pathology Industry Trends Table 12. Digital Pathology Industry Drivers Table 13. Digital Pathology Industry Opportunities and Challenges Table 14. Digital Pathology Industry Restraints Table 15. Global Digital Pathology Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Digital Pathology Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Digital Pathology Market Share by Region (2021-2026) Table 18. Global Digital Pathology Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Digital Pathology Market Share by Region (2027-2032) Table 20. Global Digital Pathology Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Digital Pathology Revenue Market Share by Players (2021-2026) Table 22. Global Digital Pathology Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Digital Pathology Key Players Headquarters & Area Served Table 24. Global Digital Pathology Players, Product Type & Application Table 25. Global Digital Pathology Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Digital Pathology by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Digital Pathology Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Digital Pathology Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Digital Pathology Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Digital Pathology Revenue Market Share by Type (2021-2026) Table 32. Global Digital Pathology Revenue Market Share by Type (2027-2032) Table 33. Global Digital Pathology Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Digital Pathology Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Digital Pathology Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Digital Pathology Revenue Market Share by Application (2021-2026) Table 37. Global Digital Pathology Revenue Market Share by Application (2027-2032) Table 38. Danaher Company Information Table 39. Danaher Business Overview Table 40. Danaher Digital Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Danaher Digital Pathology Product Portfolio Table 42. Danaher Recent Development Table 43. Hamamatsu Photonics Company Information Table 44. Hamamatsu Photonics Business Overview Table 45. Hamamatsu Photonics Digital Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Hamamatsu Photonics Digital Pathology Product Portfolio Table 47. Hamamatsu Photonics Recent Development Table 48. Roche Company Information Table 49. Roche Business Overview Table 50. Roche Digital Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Roche Digital Pathology Product Portfolio Table 52. Roche Recent Development Table 53. Philips Company Information Table 54. Philips Business Overview Table 55. Philips Digital Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Philips Digital Pathology Product Portfolio Table 57. Philips Recent Development Table 58. Olympus Company Information Table 59. Olympus Business Overview Table 60. Olympus Digital Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Olympus Digital Pathology Product Portfolio Table 62. Olympus Recent Development Table 63. PerkinElmer Company Information Table 64. PerkinElmer Business Overview Table 65. PerkinElmer Digital Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. PerkinElmer Digital Pathology Product Portfolio Table 67. PerkinElmer Recent Development Table 68. Sectra Company Information Table 69. Sectra Business Overview Table 70. Sectra Digital Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Sectra Digital Pathology Product Portfolio Table 72. Sectra Recent Development Table 73. Nikon Company Information Table 74. Nikon Business Overview Table 75. Nikon Digital Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Nikon Digital Pathology Product Portfolio Table 77. Nikon Recent Development Table 78. Definiens Company Information Table 79. Definiens Business Overview Table 80. Definiens Digital Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Definiens Digital Pathology Product Portfolio Table 82. Definiens Recent Development Table 83. 3DHISTECH Company Information Table 84. 3DHISTECH Business Overview Table 85. 3DHISTECH Digital Pathology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. 3DHISTECH Digital Pathology Product Portfolio Table 87. 3DHISTECH Recent Development Table 88. Visiopharm Company Information Table 89. Visiopharm Business Overview Table 90. Visiopharm Digital Pathology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Visiopharm Digital Pathology Product Portfolio Table 92. Visiopharm Recent Development Table 93. Apollo Enterprise Imaging Company Information Table 94. Apollo Enterprise Imaging Business Overview Table 95. Apollo Enterprise Imaging Digital Pathology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Apollo Enterprise Imaging Digital Pathology Product Portfolio Table 97. Apollo Enterprise Imaging Recent Development Table 98. Glencoe Software Company Information Table 99. Glencoe Software Business Overview Table 100. Glencoe Software Digital Pathology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Glencoe Software Digital Pathology Product Portfolio Table 102. Glencoe Software Recent Development Table 103. Indica Labs Company Information Table 104. Indica Labs Business Overview Table 105. Indica Labs Digital Pathology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Indica Labs Digital Pathology Product Portfolio Table 107. Indica Labs Recent Development Table 108. OptraSCAN Company Information Table 109. OptraSCAN Business Overview Table 110. OptraSCAN Digital Pathology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. OptraSCAN Digital Pathology Product Portfolio Table 112. OptraSCAN Recent Development Table 113. Objective Pathology Company Information Table 114. Objective Pathology Business Overview Table 115. Objective Pathology Digital Pathology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Objective Pathology Digital Pathology Product Portfolio Table 117. Objective Pathology Recent Development Table 118. Digipath Company Information Table 119. Digipath Business Overview Table 120. Digipath Digital Pathology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. Digipath Digital Pathology Product Portfolio Table 122. Digipath Recent Development Table 123. Pathcore Company Information Table 124. Pathcore Business Overview Table 125. Pathcore Digital Pathology Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. Pathcore Digital Pathology Product Portfolio Table 127. Pathcore Recent Development Table 128. North America Digital Pathology Revenue by Type (2021-2026) & (US$ Million) Table 129. North America Digital Pathology Revenue by Type (2027-2032) & (US$ Million) Table 130. North America Digital Pathology Revenue by Application (2021-2026) & (US$ Million) Table 131. North America Digital Pathology Revenue by Application (2027-2032) & (US$ Million) Table 132. North America Digital Pathology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. North America Digital Pathology Revenue by Country (2021-2026) & (US$ Million) Table 134. North America Digital Pathology Revenue by Country (US$ Million) & (2027-2032) Table 135. Europe Digital Pathology Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Digital Pathology Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Digital Pathology Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe Digital Pathology Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe Digital Pathology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe Digital Pathology Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe Digital Pathology Revenue by Country (US$ Million) & (2027-2032) Table 142. China Digital Pathology Revenue by Type (2021-2026) & (US$ Million) Table 143. China Digital Pathology Revenue by Type (2027-2032) & (US$ Million) Table 144. China Digital Pathology Revenue by Application (2021-2026) & (US$ Million) Table 145. China Digital Pathology Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia Digital Pathology Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Digital Pathology Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Digital Pathology Revenue by Application (2021-2026) & (US$ Million) Table 149. Asia Digital Pathology Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia Digital Pathology Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Asia Digital Pathology Revenue by Region (US$ Million) & (2021-2026) Table 152. Asia Digital Pathology Revenue by Region (US$ Million) & (2027-2032) Table 153. SAMEA Digital Pathology Revenue by Type (2021-2026) & (US$ Million) Table 154. SAMEA Digital Pathology Revenue by Type (2027-2032) & (US$ Million) Table 155. SAMEA Digital Pathology Revenue by Application (2021-2026) & (US$ Million) Table 156. SAMEA Digital Pathology Revenue by Application (2027-2032) & (US$ Million) Table 157. SAMEA Digital Pathology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. SAMEA Digital Pathology Revenue by Country (2021-2026) & (US$ Million) Table 159. SAMEA Digital Pathology Revenue by Country (US$ Million) & (2027-2032) Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Digital Pathology Image Figure 2. Global Digital Pathology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Pathology Market Size Share 2021 VS 2025 VS 2032 Figure 4. Whole Slide Imaging Image Figure 5. Image Analysis-Informatics Image Figure 6. Information Management System Storage & Communication Image Figure 7. Digital IVD Devices Image Figure 8. Others Image Figure 9. Global Digital Pathology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Digital Pathology Market Size Share 2021 VS 2025 VS 2032 Figure 11. Pharma & Biotech Companies Image Figure 12. Hospital & Diagnostic Centers Image Figure 13. Educational Institutes Image Figure 14. Global Digital Pathology Market Size (US$ Million) & (2021-2032) Figure 15. Global Digital Pathology Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Digital Pathology Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Digital Pathology Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Digital Pathology Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Digital Pathology Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Digital Pathology Revenue Market Share by Type (2021-2032) Figure 22. Global Digital Pathology Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Digital Pathology Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Digital Pathology Revenue Market Share by Application (2021-2032) Figure 25. North America Digital Pathology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Digital Pathology Revenue Share by Type (2021-2032) Figure 27. North America Digital Pathology Revenue Share by Application (2021-2032) Figure 28. North America Digital Pathology Revenue Share by Country (2021-2032) Figure 29. United States Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Digital Pathology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Digital Pathology Revenue Share by Type (2021-2032) Figure 34. Europe Digital Pathology Revenue Share by Application (2021-2032) Figure 35. Europe Digital Pathology Revenue Share by Country (2021-2032) Figure 36. Germany Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Digital Pathology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Digital Pathology Revenue Share by Type (2021-2032) Figure 46. China Digital Pathology Revenue Share by Application (2021-2032) Figure 47. Asia Digital Pathology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Digital Pathology Revenue Share by Type (2021-2032) Figure 49. Asia Digital Pathology Revenue Share by Application (2021-2032) Figure 50. Asia Digital Pathology Revenue Share by Region (2021-2032) Figure 51. Japan Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Digital Pathology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Digital Pathology Revenue Share by Type (2021-2032) Figure 59. SAMEA Digital Pathology Revenue Share by Application (2021-2032) Figure 60. SAMEA Digital Pathology Revenue Share by Country (2021-2032) Figure 61. Brazil Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Digital Pathology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Whole Slide Imaging
  • Image Analysis-Informatics
  • Information Management System Storage & Communication
  • Digital IVD Devices
  • Others
Applications
  • Pharma & Biotech Companies
  • Hospital & Diagnostic Centers
  • Educational Institutes
Companies covered
  • Danaher
  • Hamamatsu Photonics
  • Roche
  • Philips
  • Olympus
  • PerkinElmer
  • Sectra
  • Nikon
  • Definiens
  • 3DHISTECH
  • Visiopharm
  • Apollo Enterprise Imaging
  • Glencoe Software
  • Indica Labs
  • OptraSCAN
  • Objective Pathology
  • Digipath
  • Pathcore

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Digital Pathology Market by Type
  3. 1.2.1 Global Digital Pathology Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Whole Slide Imaging
  5. 1.2.3 Image Analysis-Informatics
  6. 1.2.4 Information Management System Storage & Communication
  7. 1.2.5 Digital IVD Devices
  8. 1.2.6 Others
  9. 1.3 Digital Pathology Market by Application
  10. 1.3.1 Global Digital Pathology Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Pharma & Biotech Companies
  12. 1.3.3 Hospital & Diagnostic Centers
  13. 1.3.4 Educational Institutes
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Digital Pathology Market Dynamics
  1. 2.1 Digital Pathology Industry Trends
  2. 2.2 Digital Pathology Industry Drivers
  3. 2.3 Digital Pathology Industry Opportunities and Challenges
  4. 2.4 Digital Pathology Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Digital Pathology Market Perspective (2021-2032)
  2. 3.2 Global Digital Pathology Growth Trends by Region
  3. 3.2.1 Global Digital Pathology Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Digital Pathology Market Size by Region (2021-2026)
  5. 3.2.3 Global Digital Pathology Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Digital Pathology Revenue by Players
  2. 4.1.1 Global Digital Pathology Revenue by Players (2021-2026)
  3. 4.1.2 Global Digital Pathology Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Digital Pathology Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Digital Pathology Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Digital Pathology Key Players Headquarters & Area Served
  7. 4.4 Global Digital Pathology Players, Product Type & Application
  8. 4.5 Global Digital Pathology Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Digital Pathology Market CR5 and HHI
  11. 4.6.3 2025 Digital Pathology Tier 1, Tier 2, and Tier 3
5 Digital Pathology Market Size by Type
  1. 5.1 Global Digital Pathology Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Digital Pathology Revenue by Type (2021-2032)
  3. 5.3 Global Digital Pathology Revenue Market Share by Type (2021-2032)
6 Digital Pathology Market Size by Application
  1. 6.1 Global Digital Pathology Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Digital Pathology Revenue by Application (2021-2032)
  3. 6.3 Global Digital Pathology Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Danaher
  2. 7.1.1 Danaher Company Information
  3. 7.1.2 Danaher Business Overview
  4. 7.1.3 Danaher Digital Pathology Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Danaher Digital Pathology Product Portfolio
  6. 7.1.5 Danaher Recent Developments
  7. 7.2 Hamamatsu Photonics
  8. 7.2.1 Hamamatsu Photonics Company Information
  9. 7.2.2 Hamamatsu Photonics Business Overview
  10. 7.2.3 Hamamatsu Photonics Digital Pathology Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Hamamatsu Photonics Digital Pathology Product Portfolio
  12. 7.2.5 Hamamatsu Photonics Recent Developments
  13. 7.3 Roche
  14. 7.3.1 Roche Company Information
  15. 7.3.2 Roche Business Overview
  16. 7.3.3 Roche Digital Pathology Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Roche Digital Pathology Product Portfolio
  18. 7.3.5 Roche Recent Developments
  19. 7.4 Philips
  20. 7.4.1 Philips Company Information
  21. 7.4.2 Philips Business Overview
  22. 7.4.3 Philips Digital Pathology Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Philips Digital Pathology Product Portfolio
  24. 7.4.5 Philips Recent Developments
  25. 7.5 Olympus
  26. 7.5.1 Olympus Company Information
  27. 7.5.2 Olympus Business Overview
  28. 7.5.3 Olympus Digital Pathology Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Olympus Digital Pathology Product Portfolio
  30. 7.5.5 Olympus Recent Developments
  31. 7.6 PerkinElmer
  32. 7.6.1 PerkinElmer Company Information
  33. 7.6.2 PerkinElmer Business Overview
  34. 7.6.3 PerkinElmer Digital Pathology Revenue and Gross Margin (2021-2026)
  35. 7.6.4 PerkinElmer Digital Pathology Product Portfolio
  36. 7.6.5 PerkinElmer Recent Developments
  37. 7.7 Sectra
  38. 7.7.1 Sectra Company Information
  39. 7.7.2 Sectra Business Overview
  40. 7.7.3 Sectra Digital Pathology Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sectra Digital Pathology Product Portfolio
  42. 7.7.5 Sectra Recent Developments
  43. 7.8 Nikon
  44. 7.8.1 Nikon Company Information
  45. 7.8.2 Nikon Business Overview
  46. 7.8.3 Nikon Digital Pathology Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Nikon Digital Pathology Product Portfolio
  48. 7.8.5 Nikon Recent Developments
  49. 7.9 Definiens
  50. 7.9.1 Definiens Company Information
  51. 7.9.2 Definiens Business Overview
  52. 7.9.3 Definiens Digital Pathology Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Definiens Digital Pathology Product Portfolio
  54. 7.9.5 Definiens Recent Developments
  55. 7.10 3DHISTECH
  56. 7.10.1 3DHISTECH Company Information
  57. 7.10.2 3DHISTECH Business Overview
  58. 7.10.3 3DHISTECH Digital Pathology Revenue and Gross Margin (2021-2026)
  59. 7.10.4 3DHISTECH Digital Pathology Product Portfolio
  60. 7.10.5 3DHISTECH Recent Developments
  61. 7.11 Visiopharm
  62. 7.11.1 Visiopharm Company Information
  63. 7.11.2 Visiopharm Business Overview
  64. 7.11.3 Visiopharm Digital Pathology Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Visiopharm Digital Pathology Product Portfolio
  66. 7.11.5 Visiopharm Recent Developments
  67. 7.12 Apollo Enterprise Imaging
  68. 7.12.1 Apollo Enterprise Imaging Company Information
  69. 7.12.2 Apollo Enterprise Imaging Business Overview
  70. 7.12.3 Apollo Enterprise Imaging Digital Pathology Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Apollo Enterprise Imaging Digital Pathology Product Portfolio
  72. 7.12.5 Apollo Enterprise Imaging Recent Developments
  73. 7.13 Glencoe Software
  74. 7.13.1 Glencoe Software Company Information
  75. 7.13.2 Glencoe Software Business Overview
  76. 7.13.3 Glencoe Software Digital Pathology Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Glencoe Software Digital Pathology Product Portfolio
  78. 7.13.5 Glencoe Software Recent Developments
  79. 7.14 Indica Labs
  80. 7.14.1 Indica Labs Company Information
  81. 7.14.2 Indica Labs Business Overview
  82. 7.14.3 Indica Labs Digital Pathology Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Indica Labs Digital Pathology Product Portfolio
  84. 7.14.5 Indica Labs Recent Developments
  85. 7.15 OptraSCAN
  86. 7.15.1 OptraSCAN Company Information
  87. 7.15.2 OptraSCAN Business Overview
  88. 7.15.3 OptraSCAN Digital Pathology Revenue and Gross Margin (2021-2026)
  89. 7.15.4 OptraSCAN Digital Pathology Product Portfolio
  90. 7.15.5 OptraSCAN Recent Developments
  91. 7.16 Objective Pathology
  92. 7.16.1 Objective Pathology Company Information
  93. 7.16.2 Objective Pathology Business Overview
  94. 7.16.3 Objective Pathology Digital Pathology Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Objective Pathology Digital Pathology Product Portfolio
  96. 7.16.5 Objective Pathology Recent Developments
  97. 7.17 Digipath
  98. 7.17.1 Digipath Company Information
  99. 7.17.2 Digipath Business Overview
  100. 7.17.3 Digipath Digital Pathology Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Digipath Digital Pathology Product Portfolio
  102. 7.17.5 Digipath Recent Developments
  103. 7.18 Pathcore
  104. 7.18.1 Pathcore Company Information
  105. 7.18.2 Pathcore Business Overview
  106. 7.18.3 Pathcore Digital Pathology Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Pathcore Digital Pathology Product Portfolio
  108. 7.18.5 Pathcore Recent Developments
8 North America
  1. 8.1 North America Digital Pathology Revenue (2021-2032)
  2. 8.2 North America Digital Pathology Revenue by Type (2021-2032)
  3. 8.2.1 North America Digital Pathology Revenue by Type (2021-2026)
  4. 8.2.2 North America Digital Pathology Revenue by Type (2027-2032)
  5. 8.3 North America Digital Pathology Revenue Share by Type (2021-2032)
  6. 8.4 North America Digital Pathology Revenue by Application (2021-2032)
  7. 8.4.1 North America Digital Pathology Revenue by Application (2021-2026)
  8. 8.4.2 North America Digital Pathology Revenue by Application (2027-2032)
  9. 8.5 North America Digital Pathology Revenue Share by Application (2021-2032)
  10. 8.6 North America Digital Pathology Revenue by Country
  11. 8.6.1 North America Digital Pathology Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Digital Pathology Revenue by Country (2021-2026)
  13. 8.6.3 North America Digital Pathology Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Digital Pathology Revenue (2021-2032)
  2. 9.2 Europe Digital Pathology Revenue by Type (2021-2032)
  3. 9.2.1 Europe Digital Pathology Revenue by Type (2021-2026)
  4. 9.2.2 Europe Digital Pathology Revenue by Type (2027-2032)
  5. 9.3 Europe Digital Pathology Revenue Share by Type (2021-2032)
  6. 9.4 Europe Digital Pathology Revenue by Application (2021-2032)
  7. 9.4.1 Europe Digital Pathology Revenue by Application (2021-2026)
  8. 9.4.2 Europe Digital Pathology Revenue by Application (2027-2032)
  9. 9.5 Europe Digital Pathology Revenue Share by Application (2021-2032)
  10. 9.6 Europe Digital Pathology Revenue by Country
  11. 9.6.1 Europe Digital Pathology Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Digital Pathology Revenue by Country (2021-2026)
  13. 9.6.3 Europe Digital Pathology Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Digital Pathology Revenue (2021-2032)
  2. 10.2 China Digital Pathology Revenue by Type (2021-2032)
  3. 10.2.1 China Digital Pathology Revenue by Type (2021-2026)
  4. 10.2.2 China Digital Pathology Revenue by Type (2027-2032)
  5. 10.3 China Digital Pathology Revenue Share by Type (2021-2032)
  6. 10.4 China Digital Pathology Revenue by Application (2021-2032)
  7. 10.4.1 China Digital Pathology Revenue by Application (2021-2026)
  8. 10.4.2 China Digital Pathology Revenue by Application (2027-2032)
  9. 10.5 China Digital Pathology Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Digital Pathology Revenue (2021-2032)
  2. 11.2 Asia Digital Pathology Revenue by Type (2021-2032)
  3. 11.2.1 Asia Digital Pathology Revenue by Type (2021-2026)
  4. 11.2.2 Asia Digital Pathology Revenue by Type (2027-2032)
  5. 11.3 Asia Digital Pathology Revenue Share by Type (2021-2032)
  6. 11.4 Asia Digital Pathology Revenue by Application (2021-2032)
  7. 11.4.1 Asia Digital Pathology Revenue by Application (2021-2026)
  8. 11.4.2 Asia Digital Pathology Revenue by Application (2027-2032)
  9. 11.5 Asia Digital Pathology Revenue Share by Application (2021-2032)
  10. 11.6 Asia Digital Pathology Revenue by Country
  11. 11.6.1 Asia Digital Pathology Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Digital Pathology Revenue by Country (2021-2026)
  13. 11.6.3 Asia Digital Pathology Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Digital Pathology Revenue (2021-2032)
  2. 12.2 SAMEA Digital Pathology Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Digital Pathology Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Digital Pathology Revenue by Type (2027-2032)
  5. 12.3 SAMEA Digital Pathology Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Digital Pathology Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Digital Pathology Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Digital Pathology Revenue by Application (2027-2032)
  9. 12.5 SAMEA Digital Pathology Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Digital Pathology Revenue by Country
  11. 12.6.1 SAMEA Digital Pathology Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Digital Pathology Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Digital Pathology Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst